Galectin Therapeutics Inc (NASDAQ:GALT)

During the Trading Day
2.51 -0.23 / -8.39%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.51 0.00 / 0.00%
 
Volume: 484.00

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization9.0K9.0K12.0K10.0K
 
 
 
 
 
 
Operating ExpensesGross Income-9.0K-9.0K-12.0K-10.0K
 
 
 
 
 
General Expenses10.4M9.9M12.1M15.3M
 
 
 
 
 
Research And Development3.6M4.5M5.7M8.4M
 
 
 
 
 
Total Operating Expenses10.4M9.9M12.1M15.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.4M-9.9M-12.1M-15.3M
 
 
 
 
 
Extraordinary Credit0.00200.0K0.000.00
 
 
Extraordinary Charge-524.0K0.000.00-150.0K
 
 
 
Pre-Tax Equity Earnings0.000.00---400.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-9.7M-12.1M-15.8M
 
 
 
 
 
Preferred Dividend-1.8M-976.0K-867.0K-943.0K
 
 
 
 
 
Net Income-10.9M-9.9M-21.1M-16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.0M15.1M16.9M21.8M
 
 
 
 
 
Shares To Calculate EPS Diluted12.0M15.1M16.9M21.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.36-$0.72-$1.30-$0.78
 
 
 
 
 
EPS Diluted-$1.08-$0.72-$1.30-$0.78
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account